home / stock / pktx / pktx news

PKTX News and Press, Protokinetix Inc

Stock Information
Company Name: Protokinetix Inc
Stock Symbol: PKTX
Market: OTC
Website: protokinetix.com
Menu
PKTX PKTX Quote PKTX Short PKTX News PKTX Articles PKTX Message Board
Get PKTX Alerts

News, Short Squeeze, Breakout and More Instantly...
PKTX - Research Paper Incorporating ProtoKinetix AAGP® Submitted to Scientific Journal for Publication

ProtoKinetix, Incorporated ( www.protokinetix.com ) (the "Company" or "ProtoKinetix") (OTCQB: PKTX ), a clinical-stage biomedical company, today announced the submission of a research paper describing cell characterization, graft evaluation, and yield of islet-like cells differentiated fr...
PKTX - ProtoKinetix Successfully Completes Phase 1 Clinical Trials for the Treatment of Type 1 Diabetes in Islet Cell Transplants

ProtoKinetix, Incorporated ( www.protokinetix.com ) (the "Company" or "ProtoKinetix") (OTCQB: PKTX ), a clinical-stage biomedical company, today announced that the University of Alberta has successfully completed Phase 1 clinical trial enrollment for the treatment of type 1 diab...

PKTX - ProtoKinetix Announces Annual General Stockholder Meeting Will Be Held Virtually Only

ProtoKinetix, Incorporated ( www.protokinetix.com ) (the "Company" or "ProtoKinetix") (OTCQB: PKTX ), a clinical-stage biomedical company, today announced that it will hold its Annual General Meeting of the Stockholders of the Company (“AGM”) virtually with no opti...

PKTX - ProtoKinetix Announces Selection of AAGP® Candidate Formulations for Treatment of Dry Eye Disease

ProtoKinetix, Incorporated ( www.protokinetix.com ) (the "Company" or "ProtoKinetix") (OTCQB: PKTX ), a clinical-stage biomedical company, today announced that it has selected two formulations of its Anti-Aging Glycopeptide (AAGP®) product to be advanced into preclinical ef...
PKTX - ProtoKinetix and IQVIA partner to support development of eye treatment

Clinical-stage biomedical company ProtoKinetix (PKTX) and IQVIA (IQV) enter into a collaboration to accelerate the development of AAGP (PKX-001) in ocular conditions, specifically dry eye disease and wet and dry forms of age-related macular degeneration.The collaboration is expected to d...

PKTX - ProtoKinetix and IQVIA Partner to Support Development of AAGP® Product in the Treatment of Ocular Conditions

ProtoKinetix, Incorporated ( www.protokinetix.com ) (the "Company" or "ProtoKinetix") (OTCQB: PKTX ), a clinical-stage biomedical company, today announced its collaboration with IQVIA (NYSE: IQV ) to accelerate development of AAGP® (PKX-001) in ocular conditions, specif...

PKTX - ProtoKinetix Announces the Resumption of Phase 1b Clinical Trials for the use of AAGP® Treated Islet Cells in the Treatment of Type 1 Diabetes

ProtoKinetix, Incorporated ( www.protokinetix.com ) (the "Company" or "ProtoKinetix") (OTCQB: PKTX) , a clinical-stage biomedical company, today announced Phase I clinical trials of AAGP® (PKX-001) treated islet cells have resumed at the University of Alberta, Edmonton. All...
PKTX - ProtoKinetix Engages Multi-National Partner for Formulation of Topical Drug to Treat Dry Eye Disease & Ocular Inflammation with AAGP®

ProtoKinetix, Incorporated (the "Company" or "ProtoKinetix") (OTCQB: PKTX ), a clinical-stage biomedical company, today announced that it has engaged a global pharmaceutical company to develop the formulation as a topical ocular drug for the treatment of dry eye disease (DED) and oc...

PKTX - Journal of Tissue Engineering and Regenerative Medicine Publishes Peer Reviewed Research Paper Establishing ProtoKinetix AAGP® Enhanced Stem Cell Vision Restoration

ProtoKinetix, Incorporated ( www.protokinetix.com ) (the "Company" or "ProtoKinetix") (OTCQB: PKTX), a clinical-stage biomedical company, today announced the publication of a peer reviewed research paper describing and interpreting the results examining the benefit provided by A...

PKTX - Research Paper Showing ProtoKinetix AAGP® Enhanced Stem Cell Derived Retina Precursor Cells Restoration of Vision

ProtoKinetix, Incorporated ( www.protokinetix.com ) (the "Company" or "ProtoKinetix") (OTCQB: PKTX ), a clinical-stage biomedical company, today announced the submission of a research paper describing and interpreting the results analysing the benefit of PKX-001 on human induced...
Next 10